Literature DB >> 26768592

Association Between Interleukin-1A, Interleukin-1B, and Bridging integrator 1 Polymorphisms and Alzheimer's Disease: a standard and Cumulative Meta-analysis.

Xiaoliu Dong1, Li Zhang2, Qingling Meng3, Qiuyan Gao4.   

Abstract

Alzheimer's disease (AD) has been one of the most prevalent health problems among senior population. Interleukin-1A (IL-1A) and IL-1B are two isoforms of IL-1. Recent studies suggested that certain polymorphisms on these two genes are associated with AD. Bridging integrator 1 (BIN1) is considered as common genetic risk factors for AD, whereas different studies have provided various conclusions regarding its role in AD. This study was designed to justify the association between multiple gene polymorphisms and AD through an evidence synthesis approach. We conducted a literature search to identify relevant articles published from 2000 to 2015 from PubMed, Embase, and Cochrane Library, in accordance with inclusion criteria. Pooled odds ratios (ORs) were calculated for the allele model. The effect estimates were summarized by both standard and cumulative meta-analysis. Finally, 54 articles with 88 independent studies were enrolled in this meta-analysis. Mutants in rs1800587 of IL-1A, rs1143634 of IL-1B, rs12989701, and rs744373 of BIN1 were significantly associated with AD onset. The difference effect of same single nucleotide polymorphisms (SNPs) on various ethnicities was also observed in our results. The present meta-analysis suggested that IL-1A, IL-1B, and BIN1 were candidate genes for AD pathogenesis. Polymorphisms of IL-1A, IL-1B, and BIN1 are associated with AD onset.

Entities:  

Keywords:  Alzheimer disease; Bridging integrator 1; Genetic association; Interleukin-1; Meta-analysis

Mesh:

Substances:

Year:  2016        PMID: 26768592     DOI: 10.1007/s12035-015-9683-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  76 in total

1.  Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients.

Authors:  K M Mattila; J O Rinne; T Lehtimäki; M Röyttä; J P Ahonen; M Hurme
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

2.  Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease.

Authors:  Andrea Flex; Silvia Giovannini; Federico Biscetti; Rosa Liperoti; Gianfranco Spalletta; Giuseppe Straface; Francesco Landi; Flavia Angelini; Carlo Caltagirone; Giovanni Ghirlanda; Roberto Bernabei
Journal:  Neurodegener Dis       Date:  2013-09-06       Impact factor: 2.977

3.  Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage.

Authors:  M O McCarron; J Stewart; P McCarron; S Love; H V Vinters; J W Ironside; D M A Mann; D I Graham; J A R Nicoll
Journal:  Stroke       Date:  2003-08-28       Impact factor: 7.914

Review 4.  Diabetes and cancer.

Authors:  T A Chowdhury
Journal:  QJM       Date:  2010-08-25

5.  Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population.

Authors:  X-Q Li; J-W Zhang; Z-X Zhang; D Chen; Q-M Qu
Journal:  J Neural Transm (Vienna)       Date:  2004-05-12       Impact factor: 3.575

6.  Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease.

Authors:  F L Sciacca; C Ferri; F Licastro; F Veglia; I Biunno; A Gavazzi; E Calabrese; F Martinelli Boneschi; S Sorbi; C Mariani; M Franceschi; L M E Grimaldi
Journal:  Neurobiol Aging       Date:  2003-11       Impact factor: 4.673

Review 7.  Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases.

Authors:  M Hurme; N Lahdenpohja; S Santtila
Journal:  Ann Med       Date:  1998-10       Impact factor: 4.709

8.  Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease.

Authors:  Christian Ehl; Heike Kölsch; Ursula Ptok; Frank Jessen; Sandra Schmitz; Christine Frahnert; Ralf Schlösser; Marie Luise Rao; Wolfgang Maier; Reinhard Heun
Journal:  Int J Mol Med       Date:  2003-02       Impact factor: 4.101

9.  Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia.

Authors:  Yu-Min Kuo; Pao-Chi Liao; Chingju Lin; Chih-Wei Wu; Hsueh-Meei Huang; Chih-Chien Lin; Liang-Jen Chuo
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Apr-Jun       Impact factor: 2.703

Review 10.  Alzheimer's disease risk genes and mechanisms of disease pathogenesis.

Authors:  Celeste M Karch; Alison M Goate
Journal:  Biol Psychiatry       Date:  2014-05-17       Impact factor: 13.382

View more
  5 in total

Review 1.  The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Authors:  Cong Zheng; Xin-Wen Zhou; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2016-04-05       Impact factor: 8.014

Review 2.  Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition.

Authors:  Paul Denver; Paula L McClean
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

3.  Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation.

Authors:  Moustafa Fathy; Michael Atef Fawzy; Henning Hintzsche; Toshio Nikaido; Thomas Dandekar; Eman M Othman
Journal:  Molecules       Date:  2019-11-03       Impact factor: 4.411

4.  Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimer's Disease in the Lithuanian Population.

Authors:  Greta Pšemeneckienė; Kęstutis Petrikonis; And Daiva Rastenytė
Journal:  Medicina (Kaunas)       Date:  2019-10-15       Impact factor: 2.430

5.  Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability.

Authors:  Yuliya Voskobiynyk; Jonathan R Roth; J Nicholas Cochran; Travis Rush; Nancy Vn Carullo; Jacob S Mesina; Mohammad Waqas; Rachael M Vollmer; Jeremy J Day; Lori L McMahon; Erik D Roberson
Journal:  Elife       Date:  2020-07-13       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.